[1]
O. B. Mihaljević, “THE ASSOCIATION OF CIRCULATING SCLEROSTIN LEVEL WITH MARKERS OF BONE METABOLISM IN PATIENTS WITH THYROID DYSFUNCTION”, J Med Biochem, vol. 39, no. 4, pp. 436–443, Jan. 2020, doi: 10.5937/jomb0-24943.